Skip to main content
. 2017 Jan 31;53(1):532–555. doi: 10.1111/1475-6773.12661

Table 4.

Logistic Regression Model on Survival after 2‐Year Follow‐Up (Intervention Group: N = 1,827, Control Group: N = 3,507)

Reference Odds Ratio CI 95% p‐value
2.5% 97.5%
Study group Control group 1.51 1.28 1.77 <.0001
Residential area (Berlin vs. rural). Rural 0.82 0.70 0.96 .0114
Age (in years) (continuous) 0.95 0.94 0.96 <.0001
Sex Male 1.18 1.03 1.36 .0197
NYHA class
NYHA II NYHA I 2.27 1.19 4.14 .0098
NYHA III NYHA I 1.69 0.89 3.08 .0943
NYHA IV NYHA I 1.23 0.64 2.24 .5217
CHF‐related hospitalization (Continuous) 0.75 0.70 0.81 <.0001
Intake of medication related to CHF (yes/no by groups of agents)
ACE inhibitors No 1.25 1.09 1.44 .0020
Beta‐blockers No 1.37 1.19 1.57 <.0001
Renin inhibitors No 1.19 0.69 2.14 .5528
Glycosides No 0.75 0.63 0.90 .0014
Diuretics No 0.59 0.51 0.69 <.0001
AT1 receptor blockers No 1.48 1.22 1.79 .0001
Mental and behavioral disorders (yes/no by blocks of ICD‐10 Chapter V)
F00–F09 (Organic, including symptomatic, mental disorders) No 0.58 0.47 0.72 <.0001
F10–F19 (Mental and behavioral disorders due to psychoactive substance use) No 0.72 0.57 0.92 .0081
F20–F29 (Schizophrenia, schizotypal, and delusional disorders) No 1.41 0.66 3.32 .4031
F30–F39 (Mood [affective] disorders) No 1.02 0.85 1.23 .8399
F40–F49 (Neurotic, stress‐related, and somatoform disorders) No 1.10 0.90 1.36 .3424
F50–F59 (Behavioral syndromes associated with physiological disturbances and physical factors) No 1.03 0.70 1.54 .8930
F60–F69 (Disorders of adult personality and behavior) No 0.94 0.52 1.79 .8450
F70–F79 (Mental retardation) No 0.96 0.35 3.11 .9373
F80–F89 (Disorders of psychological development) No
F90–F98 (Behavioral and emotional disorders with onset usually occurring in childhood and adolescence) No 1.30 0.33 8.90 .7428
F99–F99 (Unspecified mental disorders) No 0.58 0.17 2.46 .4162
Intercept 122.76 50.43 308.19 <.0001